Bill > S2198

This bill requires the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain. The study will cover the types, magnitude, and prevalence of these structures between different intermediaries in the supply chain, such as pharmacy benefit managers, plan sponsors, wholesalers, pharmacies, and manufacturers. It will also examine the primary business models and compensation structures for each intermediary, variations between affiliated and unaffiliated entities, potential conflicts of interest, and patterns and trends in price-based compensation structures over time and across different market segments. The report, due within 2 years of the bill's enactment, will include recommendations for appropriate legislation and administrative action.

Budget and Finance

https://www.congress.gov/bill/118th-congress/senate-bill/2198/all-info